BBP vs. PFFA
BBP (Virtus LifeSci Biotech Products ETF) and PFFA (Virtus InfraCap U.S. Preferred Stock ETF) are both exchange-traded funds - BBP is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Products Index, while PFFA is a Preferred Stock/Convertible Bonds fund actively managed by Virtus Investment Partners. BBP is passively managed, while PFFA is actively managed. Over the past 5 years, BBP returned 10.37%/yr vs 6.57%/yr for PFFA. At a 0.35 correlation, their price movements are largely independent. BBP charges 0.79%/yr vs 1.47%/yr for PFFA.
Performance
BBP vs. PFFA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBP achieves a 5.80% return, which is significantly higher than PFFA's 3.08% return.
BBP
- 1D
- 1.18%
- 1M
- -3.14%
- YTD
- 5.80%
- 6M
- 7.91%
- 1Y
- 45.02%
- 3Y*
- 16.70%
- 5Y*
- 10.37%
- 10Y*
- 11.61%
PFFA
- 1D
- -0.70%
- 1M
- -0.26%
- YTD
- 3.08%
- 6M
- 4.03%
- 1Y
- 14.79%
- 3Y*
- 14.46%
- 5Y*
- 6.57%
- 10Y*
- —
BBP vs. PFFA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
BBP Virtus LifeSci Biotech Products ETF | 5.80% | 33.15% | 3.32% | 17.88% | 0.85% | -8.17% | 22.24% | 24.73% | -19.99% |
PFFA Virtus InfraCap U.S. Preferred Stock ETF | 3.08% | 8.22% | 16.11% | 26.45% | -20.91% | 23.53% | -7.87% | 31.99% | -7.10% |
Correlation
The correlation between BBP and PFFA is 0.40, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.40 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.36 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.37 |
Correlation (All Time) Calculated using the full available price history since May 17, 2018 | 0.35 |
BBP vs. PFFA - Sectors Allocation Comparison
Sectors
BBP
PFFA
Healthcare
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
BBP
PFFA
Basic Materials
BBP
-
PFFA
Communication Services
BBP
-
PFFA
Consumer Cyclical
BBP
-
PFFA
Consumer Defensive
BBP
-
PFFA
-
Energy
BBP
-
PFFA
Financial Services
BBP
-
PFFA
Industrials
BBP
-
PFFA
Real Estate
BBP
-
PFFA
Technology
BBP
-
PFFA
Utilities
BBP
-
PFFA
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBP vs. PFFA — Risk / Return Rank
BBP
PFFA
BBP vs. PFFA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and Virtus InfraCap U.S. Preferred Stock ETF (PFFA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBP | PFFA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.21 | ||
| Sortino ratioReturn per unit of downside risk | -0.27 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 1.40 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | 4.87 | 2.29 | +2.58 |
| Martin ratioReturn relative to average drawdown | 15.32 | 7.79 | +7.53 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BBP | PFFA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.91 | 2.12 | -0.21 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.40 | 0.57 | -0.18 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.42 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.39 | 0.24 | +0.15 |
Drawdowns
BBP vs. PFFA - Drawdown Comparison
The maximum BBP drawdown since its inception was -44.32%, smaller than the maximum PFFA drawdown of -70.52%. Use the drawdown chart below to compare losses from any high point for BBP and PFFA.
Loading charts...
Drawdown Indicators
| BBP | PFFA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.32% | -70.52% | +26.20% |
Max Drawdown (1Y)Largest decline over 1 year | -9.28% | -6.49% | -2.79% |
Max Drawdown (3Y)Largest decline over 3 years | -26.09% | -12.15% | -13.94% |
Max Drawdown (5Y)Largest decline over 5 years | -38.28% | -22.70% | -15.58% |
Max Drawdown (10Y)Largest decline over 10 years | -44.32% | — | — |
Current DrawdownCurrent decline from peak | -6.47% | -1.50% | -4.97% |
Average DrawdownAverage peak-to-trough decline | -12.02% | -6.65% | -5.37% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.95% | 1.90% | +1.05% |
Volatility
BBP vs. PFFA - Volatility Comparison
Virtus LifeSci Biotech Products ETF (BBP) has a higher volatility of 7.61% compared to Virtus InfraCap U.S. Preferred Stock ETF (PFFA) at 1.87%. This indicates that BBP's price experiences larger fluctuations and is considered to be riskier than PFFA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBP | PFFA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.61% | 1.87% | +5.74% |
Volatility (6M)Calculated over the trailing 6-month period | 18.43% | 5.68% | +12.75% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.76% | 7.02% | +16.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.35% | 11.51% | +14.84% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.40% | 31.84% | -4.44% |
BBP vs. PFFA - Expense Ratio Comparison
BBP has a 0.79% expense ratio, which is lower than PFFA's 1.47% expense ratio.
Dividends
BBP vs. PFFA - Dividend Comparison
BBP has not paid dividends to shareholders, while PFFA's dividend yield for the trailing twelve months is around 9.62%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBP Virtus LifeSci Biotech Products ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 1.29% |
PFFA Virtus InfraCap U.S. Preferred Stock ETF | 9.62% | 9.47% | 9.18% | 9.56% | 10.75% | 7.64% | 8.54% | 10.02% | 5.15% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BBP and PFFA have a correlation of 0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBP has higher volatility (7.61%) compared to PFFA (1.87%). In terms of maximum drawdown, BBP dropped -44.32% vs PFFA's -70.52%.
On 5-year performance, BBP leads with 10.37% vs 6.57% for PFFA. On fees, BBP is cheaper at 0.79% per year. On volatility, PFFA has been the lower-risk option at 1.87%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, BBP has performed better with a 10.37% return vs 6.57%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
BBP is cheaper with a 0.79% expense ratio, compared with 1.47% for PFFA.
PFFA has the higher dividend yield at 9.62%, compared with 0.00% for BBP.
BBP is categorized as Health & Biotech Equities, while PFFA is Preferred Stock/Convertible Bonds. Their fees differ too: 0.79% for BBP and 1.47% for PFFA.
PFFA currently has the higher Sharpe Ratio (2.12 vs 1.91), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBP and PFFA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer